Q-Pam

ANDA 70424, held by Quantum Pharmics. Diazepam.

As of Nov 14, 2026, ANDA 70424 (Q-Pam), held by Quantum Pharmics, was not approved, with 2 approved supplements and 0 published complete response letters.

First approved: Not approved
Supplements approved: 2
Complete response letters: 0

Products

1 strengths and forms

Product	Active ingredient	Marketing
Q-Pam5MG · tablet;oral	Diazepam	Discontinued

All 2 submissions, including labeling and manufacturing supplements


Apr 16, 1987	Supplement 2Manufacturing	Approved	None posted
Apr 16, 1987	Supplement 4Manufacturing	Approved	None posted

Identifiers

Application: ANDA 70424
Drugs@FDA: Overview at FDA
Company: Quantum Pharmics

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters